Yun Chang

This body of work spans stem cell biology and gene-editing approaches, including using induced pluripotent stem cells (cells reprogrammed from adult tissue that can become almost any cell type) to model diseases and generate therapeutic cell types such as cardiac, endothelial, and immune cells. It also covers engineering immune cells (like CAR-T and CAR-macrophage therapies) and CRISPR-based gene editing for treating conditions such as heart disease and cancer. Note that the publication list appears to mix in unrelated topics (e.g., particle detector hardware, alkaloid chemistry, infrared radiation of ballistic targets), suggesting this record may combine outputs from multiple researchers sharing the same name.

Publication output has fluctuated over the past decade, rising to a peak around 2021 before declining and then partially recovering by 2025, averaging about 9 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026